Are subclavian percutaneous central venous catheters an alternative to Hickman-Broviac catheters in neonates and young infants?
DOI:
https://doi.org/10.52783/jns.v13.1304Downloads
Metrics
References
Kammoun M, Jarraya A, Ketata H, Ammar S, Zouari M, Regaieg C, et al. Risk factors for Hickman-Broviac catheter complications: An experience from a Tunisian hospital. J Neonatal Surg. 2022;11:26.
Kammoun M, Jarraya A, Ammar S, Kolsi k. Improvement of Broviac catheter-related outcomes after the implementation of a quality management system: A before-and-after prospective observational study. J Neonatal Surg. 2023;12:3.
Jarraya A, Kammoun M, Chtourou A, Ammar S, Kolsi K. Complications and its risk factors of percutaneous subclavian vein catheters in pediatric patients: enhancing the outcomes of a university hospital in a low-income and middle-income country. World J Pediatr Surg. 2023;6:e000523.
Jarraya A, Kammoun M, Sarhan A, Abdelhedi A, Kolsi K. Percutaneous infraclavicular subclavian vein catheters in paediatric cancer patients in comparison with critically ill children: a one-year experience from a Tunisian hospital. Br J Nurs. 2024;33:S28-S32.
Chen IL, Ou-Yang MC, Chen FS, Chung MY, Chen CC, Liu YC, et al. The equations of the inserted length of percutaneous central venous catheters on neonates in NICU. Pediatr Neonatol. 2019;60:305-310.
Hosseinpour M, Mashadi MR, Behdad S, Azarbad Z. Central venous catheterization in neonates: Comparison of complications with percutaneous and open surgical methods. J Indian Assoc Pediatr Surg. 2011;16:99-101.

Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Anouar Jarraya, Manel Kammoun, Olfa Cherif, Mariem Ben Abdallah

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.